Abstract
A structure-activity relationship (SAR) dataset was generated for a set of acetylcholinesterase inhibitors using Adaboost and physicochemical parameters. After calculation, it is found that the ACC of SAR model is 99.51 by using 10-fold cross-validation test, while 99.35% for independent test set. Based on the SAR prediction model, bakuchiol is predicted to be an acetylcholinesterase inhibitor. Fluorescence was used to investigate the binding between bakuchiol and acetylcholinesterase, which can provide valuable qualitative and quantitative information about the interaction between acetylcholinesterase and bakuchiol.
Keywords: Molecular descriptors, acetylcholinesterase, bakuchiol, Adaboost.
Graphical Abstract
Current Bioinformatics
Title:Prediction of an Interaction between Bakuchiol and Acetylcholinesterase using Adaboost
Volume: 11 Issue: 1
Author(s): Can Zhang, Xueyuan Wang, Lei Gu, Li Jiang, Qiang Su, Manman Zhao, Linfeng Zheng, Ling Tang, Fuxue Chen and Bing Niu
Affiliation:
Keywords: Molecular descriptors, acetylcholinesterase, bakuchiol, Adaboost.
Abstract: A structure-activity relationship (SAR) dataset was generated for a set of acetylcholinesterase inhibitors using Adaboost and physicochemical parameters. After calculation, it is found that the ACC of SAR model is 99.51 by using 10-fold cross-validation test, while 99.35% for independent test set. Based on the SAR prediction model, bakuchiol is predicted to be an acetylcholinesterase inhibitor. Fluorescence was used to investigate the binding between bakuchiol and acetylcholinesterase, which can provide valuable qualitative and quantitative information about the interaction between acetylcholinesterase and bakuchiol.
Export Options
About this article
Cite this article as:
Zhang Can, Wang Xueyuan, Gu Lei, Jiang Li, Su Qiang, Zhao Manman, Zheng Linfeng, Tang Ling, Chen Fuxue and Niu Bing, Prediction of an Interaction between Bakuchiol and Acetylcholinesterase using Adaboost, Current Bioinformatics 2016; 11 (1) . https://dx.doi.org/10.2174/1574893611666151119220248
DOI https://dx.doi.org/10.2174/1574893611666151119220248 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Update on Pharmacological Treatment of Progressive Myoclonus Epilepsies
Current Pharmaceutical Design Prader-Willi Syndrome: Genetics, Phenotype, and Management
Current Psychiatry Reviews Propolis Extract Regulates microRNA Expression in Glioblastoma and Brain Cancer Stem Cells
Anti-Cancer Agents in Medicinal Chemistry Targeted Blockade of TARP-γ8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611)
CNS & Neurological Disorders - Drug Targets Advances in Neuroimaging for HIV-1 Associated Neurological Dysfunction: Clues to the Diagnosis, Pathogenesis and Therapeutic Monitoring
Current HIV Research Dietary and Plant Polyphenols Exert Neuroprotective Effects and Improve Cognitive Function in Cerebral Ischemia
Recent Patents on Food, Nutrition & Agriculture The Control of Male Sexual Responses
Current Pharmaceutical Design Behavioral Intervention Technologies and Psychotherapy with Youth: A Review of the Literature
Current Psychiatry Reviews Clinical Pharmacogenetics and Potential Application in Personalized Medicine
Current Drug Metabolism Regulatory Triangle of Neurodegeneration, Adult Neurogenesis and MicroRNAs
CNS & Neurological Disorders - Drug Targets Introduction: P2 Receptors
Current Topics in Medicinal Chemistry Hallucinations Associated with Topiramate Therapy: A Case Report and Review of the Literature
Current Drug Safety Advances in Drug Delivery from Nose to Brain: An Overview
Current Drug Therapy Update on COX-2 Selective Inhibitors: Chemical Classification, Side Effects and their Use in Cancers and Neuronal Diseases
Current Topics in Medicinal Chemistry Abnormalities of Cortical Thickness in Pediatric Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis
Current Medical Imaging Management of Incidental Findings in the Era of Next-generation Sequencing
Current Genomics Voltage-Gated Sodium Channel Blockers; Target Validation and Therapeutic Potential
Current Topics in Medicinal Chemistry Novel Hybrid Anticonvulsants Derived from Pyrrolidine-2,5-dione Scaffold with Broad Spectrum of Activity in the Preclinical Studies
Current Topics in Medicinal Chemistry Drugs from the Sea: Conopeptides as Potential Therapeutics
Current Medicinal Chemistry Long-Term Outcome of Infants Born Late Preterm
Current Pediatric Reviews